BOLT PROJECTS Surges 26% After Merger and Stock Split

Introduction

BOLT PROJECTS HOLDINGS INC (Nasdaq: BSLK) is a Berkeley, California–based material solutions company that develops sustainable biomaterials for the fashion and beauty industries. Founded in 2009 as Bolt Threads, the company applies biotechnology and artificial intelligence to replicate and refine nature’s processes, utilizing inputs such as yeast, water, sugar, and salt. On August 14, 2024, following a merger with Golden Arrow Merger Corp (Nasdaq: GAMC), the combined entity began trading on the Nasdaq Stock Market under the ticker symbol BSLK.

Corporate Structure

As of mid-2025, BOLT PROJECTS employs between 11 and 50 people, according to its LinkedIn profile. Dan Widmaier serves as founder and chief executive officer, overseeing the organization’s transition from private startup to publicly traded company. Jacob W. Doft serves as chairman of the board. The company's research and development initiatives are supported by a patent portfolio that includes 49 granted patents and 171 applications pending examination.

Biomaterials by Pawel Czerwinski

Recent Developments and News

On August 9, 2024, shareholders of Golden Arrow Merger Corp approved the merger that created BOLT PROJECTS. The new shares began trading under the symbol BSLK five days later. In an Equity Corporate Actions Alert dated April 17, 2025, Nasdaq announced a reverse stock split and change of CUSIP number for the company, effective that same day. Market data for July 8, 2025, indicates a share price of $3.15, reflecting a 26.00 percent increase on volume of 2,432,586 shares. The company's flagship biomaterial, b-silk™, is included in products such as Vegamour haircare formulations and Kelly Slater’s Freaks of Nature sunscreen.

Financial and Strategic Aspects

Since its public listing, BOLT PROJECTS has shown share-price volatility, evidenced by the 26 percent increase on July 8, 2025. The company's investments in biotechnology research and development are reflected in its patent filings, which may support potential licensing or co-development agreements. Revenue streams primarily originate from material sales to fashion and beauty brands, with opportunities for growth through additional partnerships and commercial scale-up of b-silk™ and other biobased polymers. The April 17, 2025, reverse stock split aims to streamline the company's capital structure and ensure compliance with Nasdaq listing standards.

Market Position and Industry Context

BOLT PROJECTS operates within a broader shift in fashion and personal care toward sustainability and green chemistry. By replacing petroleum-based polymers and non-biodegradable materials with nature-inspired alternatives, the company aligns with regulatory and consumer trends that emphasize environmental impact. Its use of biotechnology and AI to enhance material discovery sets it apart from traditional polymer producers. As global demand for eco-friendly beauty and textile ingredients rises, BOLT PROJECTS aims to leverage its patented processes and existing commercial partnerships to establish a share in the biomaterials market.

TL;DR

On August 14, 2024, BOLT PROJECTS HOLDINGS INC began trading as BSLK following its merger with Golden Arrow Merger Corp. A reverse stock split and CUSIP update took effect on April 17, 2025. As of July 8, 2025, shares are priced at $3.15, reflecting a 26.00 percent increase on a volume of 2.43 million, supported by the adoption of its b-silk™ biomaterial by brands and the company’s expanding patent portfolio. Future developments may include new commercial collaborations, additional patent grants, and quarterly revenue reporting.